Trial intelligence / Profile preview

Dihydroartemisinin + piperaquine for uncomplicated falciparum malaria in Somalia

ACTRN12616001005448Phase 4Completed

Sponsor
Abdullahi Mohamed Hassan
Start
Aug 2016
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of dihydroartemisinin and piperaquine, sponsored by Abdullahi Mohamed Hassan. Started Aug 2016; status: completed.

02

Drugs

dihydroartemisininpiperaquine

Beyond the preview

Go deeper on ACTRN12616001005448.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616001005448.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call